VTIV Insider Trading Activity and SEC Form 4 Filings
VTIV insider trading summary
No open-market insider purchases or sales of Inventiv Health Inc (VTIV) have been reported on SEC Form 4 in the past 12 months.
Latest VTIV insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 15, 2010 | Eran Broshy | Director | Buy | $574K (22,806 @ $25.15) |
| Mar 26, 2010 | Terrell G Herring | Director | Sell | $375K (18,750 @ $20.00) |
| Mar 26, 2010 | Terrell G Herring | Director | Sell | $356K (18,750 @ $19.00) |
| Jun 12, 2009 | A Clayton Perfall | Director | Sell | $327K (24,375 @ $13.41) |
| Jun 11, 2009 | A Clayton Perfall | Director | Sell | $346K (25,625 @ $13.52) |
| Jun 10, 2009 | A Clayton Perfall | Director | Sell | $191K (14,574 @ $13.10) |
| Jun 9, 2009 | A Clayton Perfall | Director | Sell | $334K (25,526 @ $13.10) |
| Jun 8, 2009 | A Clayton Perfall | Director | Sell | $130K (9,900 @ $13.10) |
| Mar 17, 2009 | David S Bassin | Chief Financial Officer | Buy | $38K (5,000 @ $7.50) |
| Mar 10, 2009 | Blane Walter | CEO, inVentiv Health, Inc. | Buy | $926K (133,660 @ $6.93) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.